Exploring the memory of the extracellular matrix using MASH-derived decellularized scaffolds

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Organ Transplantation

Background:

• The extracellular matrix (ECM) is increasingly recognized for its role in cell behavior and tissue regeneration.
• Bioengineering organs from diseased ECM could address organ shortages, but the ECM's potential
• memory" requires investigation.", "Metabolic dysfunction-associated steatohepatitis (MASH) presents a significant challenge in liver disease and transplantation."], "Purpose_of_the_Study": ["To determine if ECM derived from MASH livers retains a pathological memory that influences disease progression post-transplantation.", "To investigate the molecular and cellular mechanisms by which MASH-ECM affects liver cell physiology.", "To assess the potential of diseased ECM as a scaffold for bioengineered organs."], "Main_Methods": ["Decellularized ECM from MASH and control livers was used for partial orthotopic transplantation in recipient animals.", "Histological, molecular, and metabolomic analyses were performed to assess recellularization and disease markers.", "In vitro studies examined the impact of MASH-ECM on cell signaling and phenotype maintenance."], "Main_Results": ["Complete recellularization of MASH-derived ECM was achieved in all recipients.", "MASH ECM significantly stimulated de novo lipogenesis and fibrogenesis, impairing lipid oxidation.", "MASH ECM disrupted calcium signaling and promoted a pathological cellular phenotype, driving disease progression through altered lipid turnover and inflammation."], "Conclusions": ["The extracellular matrix (ECM) possesses a functional memory that can drive disease progression independently of the cellular environment.", "Diseased ECM, specifically from MASH livers, retains pathological characteristics that promote metabolic dysfunction and fibrosis.", "Strategies to reverse the pathological memory of diseased ECM are necessary for its successful application in liver transplantation and bioengineering."]}, Meta_Description=
• Diseased liver ECM memory drives disease progression post-transplantation. Research explores reversing this pathology for bioengineered organs.
• Enhanced_Abstract.Area_of_Science
• Enhanced_Abstract.Background
• Enhanced_Abstract.Purpose_of_the_Study
• Enhanced_Abstract.Main_Methods
• Enhanced_Abstract.Main_Results
• Enhanced_Abstract.Conclusions
• Meta_Description
• TL_DR
• default_api.SEOContent
• print
• tool_code
• {"Area_of_Science": ["Biomaterials Science", "Regenerative Medicine", "Organ Transplantation"], "Background": ["The extracellular matrix (ECM) is increasingly recognized for its role in cell behavior and tissue regeneration.", "Bioengineering organs from diseased ECM could address organ shortages, but the ECM's potential "memory" requires investigation.", "Metabolic dysfunction-associated steatohepatitis (MASH) presents a significant challenge in liver disease and transplantation."], "Purpose_of_the_Study": ["To determine if ECM derived from MASH livers retains a pathological memory that influences disease progression post-transplantation.", "To investigate the molecular and cellular mechanisms by which MASH-ECM affects liver cell physiology.", "To assess the potential of diseased ECM as a scaffold for bioengineered organs."], "Main_Methods": ["Decellularized ECM from MASH and control livers was used for partial orthotopic transplantation in recipient animals.", "Histological, molecular, and metabolomic analyses were performed to assess recellularization and disease markers.", "In vitro studies examined the impact of MASH-ECM on cell signaling and phenotype maintenance."], "Main_Results": ["Complete recellularization of MASH-derived ECM was achieved in all recipients.", "MASH ECM significantly stimulated de novo lipogenesis and fibrogenesis, impairing lipid oxidation.", "MASH ECM disrupted calcium signaling and promoted a pathological cellular phenotype, driving disease progression through altered lipid turnover and inflammation."], "Conclusions": ["The extracellular matrix (ECM) possesses a functional memory that can drive disease progression independently of the cellular environment.", "Diseased ECM, specifically from MASH livers, retains pathological characteristics that promote metabolic dysfunction and fibrosis.", "Strategies to reverse the pathological memory of diseased ECM are necessary for its successful application in liver transplantation and bioengineering."]}
• Diseased liver ECM memory drives disease progression post-transplantation. Research explores reversing this pathology for bioengineered organs.
• The extracellular matrix (ECM) from fatty livers retains a "memory" that promotes disease progression after transplantation. This diseased ECM scaffold can drive pathology independently of cells, hindering bioengineered organ use.

Purpose of the Study:

• To determine if ECM derived from MASH livers retains a pathological memory that influences disease progression post-transplantation.
• To investigate the molecular and cellular mechanisms by which MASH-ECM affects liver cell physiology.
• To assess the potential of diseased ECM as a scaffold for bioengineered organs.

Main Methods:

• Decellularized ECM from MASH and control livers was used for partial orthotopic transplantation in recipient animals.
• Histological, molecular, and metabolomic analyses were performed to assess recellularization and disease markers.
• In vitro studies examined the impact of MASH-ECM on cell signaling and phenotype maintenance.

Main Results:

• Complete recellularization of MASH-derived ECM was achieved in all recipients.
• MASH ECM significantly stimulated de novo lipogenesis and fibrogenesis, impairing lipid oxidation.
• MASH ECM disrupted calcium signaling and promoted a pathological cellular phenotype, driving disease progression through altered lipid turnover and inflammation.

Conclusions:

• The extracellular matrix (ECM) possesses a functional memory that can drive disease progression independently of the cellular environment.
• Diseased ECM, specifically from MASH livers, retains pathological characteristics that promote metabolic dysfunction and fibrosis.
• Strategies to reverse the pathological memory of diseased ECM are necessary for its successful application in liver transplantation and bioengineering.